Kenji Shima

Summary

Country: Japan

Publications

  1. ncbi Stringent glycaemic control prolongs survival in diabetic patients with end-stage renal disease on haemodialysis
    Kenji Shima
    Department of Medicine, Kawashima Hospital, Tokushima, Japan
    Nephrology (Carlton) 15:632-8. 2010
  2. ncbi Lower value of glycated haemoglobin relative to glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis
    Kenji Shima
    Department of Medicine, Kawashima Hospital, Tokushima 770 8540, Japan
    Ann Clin Biochem 49:68-74. 2012
  3. ncbi Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA)
    Keiko Chujo
    Kawashima Hospital, Tokushima
    J Med Invest 53:223-8. 2006

Collaborators

  • Keiko Chujo
  • Teruyo Oohashi
  • Hiroaki Tada
  • Syu Kawashima
  • Jun Minakuchi

Detail Information

Publications3

  1. ncbi Stringent glycaemic control prolongs survival in diabetic patients with end-stage renal disease on haemodialysis
    Kenji Shima
    Department of Medicine, Kawashima Hospital, Tokushima, Japan
    Nephrology (Carlton) 15:632-8. 2010
    ..No suitable index or optimal target for diabetic control has been established for diabetic patients with end-stage renal disease (ESRD) undergoing haemodialysis. To address these issues, the single-centre observational study was conducted...
  2. ncbi Lower value of glycated haemoglobin relative to glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis
    Kenji Shima
    Department of Medicine, Kawashima Hospital, Tokushima 770 8540, Japan
    Ann Clin Biochem 49:68-74. 2012
    ..However, it is unknown as to whether this is also true for diabetic patients with end-stage renal disease but not on haemodialysis...
  3. ncbi Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA)
    Keiko Chujo
    Kawashima Hospital, Tokushima
    J Med Invest 53:223-8. 2006
    ..HbAlc levels for diabetics with ESRD were lower than indicated by their blood glucose control. When assessing blood glucose control based solely on HbAlc, erroneous results may be obtained. In such cases, GA may be used instead of HbAlc...